On the Use of Overt Anti-Counterfeiting Technologies

References

• Ahmadi R, Yang BR (2000) Parallel imports: Challenges from unauthorized distribution channels. Marketing Sci. 19(3):279–294.Link, Google Scholar
• Amaldoss W, Jain S (2005) Conspicuous consumption and sophisticated thinking. Management Sci. 51(10):1449–1466.Link, Google Scholar
• Autrey R, Bova F, Soberman D (2014) Organizational structure and gray markets. Marketing Sci. 33(6):849–870.Link, Google Scholar
• Balasubramanian S (1998) Mail versus mall: A strategic analysis of competition between direct marketers and conventional retailers. Marketing Sci. 17(3):181–195.Link, Google Scholar
• Banerjee AV (1992) A simple model of herd behavior. Quart. J. Econom. 107(3):797–817.Crossref, Google Scholar
• Bate R (2012) Phake: The Deadly World of Falsified and Substandard Medicines (AEI Press, Washington, DC).Google Scholar
• Bate R, Boateng K (2007) Drug pricing and its discontents: At home and abroad. Health Policy Outlook 9:1–9.Google Scholar
• Bate R, Hess K (2010) Assessing website pharmacy drug quality: Safer than you think? PLoS ONE 5(8):e12199.Crossref, Google Scholar
• Bate R, Jin GZ, Mathur A (2011) Does price reveal poor-quality drugs? Evidence from 17 countries. J. Health Econom. 30(6):1150–1163.Crossref, Google Scholar
• Bate R, Jin GZ, Mathur A (2013) In whom we trust: The role of certification agencies in online drug markets. B.E. J. Econom. Anal. Policy 14(1):111–150.Crossref, Google Scholar
• Bate R, Jin GZ, Mathur A (2015) Falsified or substandard? Assessing price and non-price signals of drug quality. J. Econom. Management Strategy 24(4):687–711.Crossref, Google Scholar
• Bikhchandani S, Hirshleifer D, Welch I (1992) A theory of fads, fashion, custom, and cultural changes as information cascades. J. Political Econom. 100(5):992–1026.Crossref, Google Scholar
• Björkman-Nyqvist M, Svensson J, Yanagizawa-Drott D (2013) The market for (fake) antimalarial medicine: Evidence from Uganda. Working paper, Stockholm School of Economics, Stockholm.Google Scholar
• Center for Medicine in the Public Interest (2006) Counterfeit drugs and China new. Accessed April 8, 2016, http://www.cmpi.org/in-the-news/testimony/counterfeit-drugs-and-china-new.Google Scholar
• Cho S-H, Fang X, Tayur S (2015) Combating strategic counterfeiters in licit and illicit supply chains. Manufacturing Service Oper. Management 17(3):273–289.Link, Google Scholar
• Conner KR, Rumelt RP (1991) Software piracy: An analysis of protection strategies. Management Sci. 37(2):125–139.Link, Google Scholar
• Ellison G, Ellison SF (2011) Strategic entry deterrence and the behavior of pharmaceutical incumbents prior to patent expiration. Amer. Econom. J.: Microeconomics 3(1):1–36.Crossref, Google Scholar
• Givon M, Mahajan V, Muller E (1995) Software piracy: Estimation of lost sales and the impact on software diffusion. J. Marketing 59(1):29–37.Crossref, Google Scholar
• Global Industry Analyst (2010) Anti-counterfeit packaging—A global market report. Accessed April 8, 2016, http://www.strategyr.com/Anti_Counterfeit_Packaging_Market_Report.asp.Google Scholar
• Grossman GM, Shapiro C (1988a) Counterfeit-product trade. Amer. Econom. Rev. 78(1):59–75.Google Scholar
• Grossman GM, Shapiro C (1988b) Foreign counterfeiting of status goods. Quart. J. Econom. 103(1):79–100.Crossref, Google Scholar
• Guo L, Meng X (2015) Digital content provision and optimal copyright protection. Management Sci. 61(5):1183–1196.Link, Google Scholar
• Haiken M (2013) Up to 77 percent of Viagra bought online may be fake, and possibly dangerous, research shows. Forbes (September 12). http://www.forbes.com/sites/melaniehaiken/2013/09/12/buying-viagra-online-its-very-likely-fake-and-possibly-dangerous-new-data-say/.Google Scholar
• Han YJ, Nunes JC, Drèze X (2010) Signaling status with luxury goods: The role of brand prominence. J. Marketing 74(4):15–30.Crossref, Google Scholar
• Heal G (1980) Spatial structure in the retail trade: A study in product differentiation with increasing returns. Bell J. Econom. 11(2):565–583.Crossref, Google Scholar
• IMS Institute for Healthcare Informatics (2011) The global use of medicines: Outlook through 2015. Accessed April 2016, https://www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/Documents/The_Global_Use_of_Medicines_Report.pdf.Google Scholar
• Iyer G, Katona Z (2016) Competing for attention in social communication markets. Management Sci. 62(8):2304–2320.Link, Google Scholar
• Jain S (2008) Digital piracy: A competitive analysis. Marketing Sci. 27(4):610–626.Link, Google Scholar
• Jerath K, Netessine S, Veeraraghavan SK (2010) Revenue management with strategic customers: Last-minute selling and opaque selling. Management Sci. 56(3):430–448.Link, Google Scholar
• Jerath K, Sajeesh S, Zhang ZJ (2016) A model of unorganized and organized retailing in emerging economies. Marketing Sci. 35(5):756–778.Link, Google Scholar
• Lal R, Matutes C (1994) Retail pricing and advertising strategies. J. Bus. 67(3):345–370.Crossref, Google Scholar
• Lal R, Rao RC (1997) Supermarket competition: The case of every day low pricing. Marketing Sci. 16(1):60–80.Link, Google Scholar
• Lechleiter J (2012) Exposing and eradicating the dark world of fake pharmaceuticals. Forbes (August 22). http://www.forbes.com/sites/johnlechleiter/2012/08/22/exposing-and-eradicating-the-dark-world-of-fake-pharmaceuticals/#2c11820817aa.Google Scholar
• Lin H, Zhang S (2007) Selling the unused drugs? It is illegal. Guangzhou Daily (February 7). http://gzdaily.dayoo.com/html/2007-02/07/.Google Scholar
• Mailath GJ, Okuno-Fujiwara M, Postlewaite A (1993) Belief-based refinements in signalling games. J. Econom. Theory 60(2):241–276.Crossref, Google Scholar
• Mejias-Brizuela NY, Olivares-Pérez A, Ortiz-Gutiérrez M (2012) Replication of holograms with corn syrup by rubbing. Materials 5:1462–1476.Crossref, Google Scholar
• Miklós-Thal J, Zhang J (2013) (De)marketing to manage consumer quality inferences. J. Marketing Res. 50(1):55–69.Crossref, Google Scholar
• Moran B (2013) Cracking down on counterfeit drugs. Accessed April 8, 2016, http://www.pbs.org/wgbh/nova/next/body/uncovering-counterfeit-medicines/.Google Scholar
• Muth JF (1961) Rational expectations and the theory of price movements. Econometrica 29(3):315–335.Crossref, Google Scholar
• Newton PN, Dondorp A, Green M, Mayxay M, White NJ (2003) Counterfeit artesunate antimalarials in Southeast Asia. Lancet 362(9378):169.Crossref, Google Scholar
• Nichols DA, Smolensky E, Tideman TN (1971) Discrimination by waiting time in merit goods. Amer. Econom. Rev. 61(3):312–323.Google Scholar
• Organisation for Economic Co-operation and Development (2009) Magnitude of counterfeiting and piracy of tangible products: An update. Accessed April 8, 2016, http://www.unodc.org/documents/southeastasiaandpacific//Publications/2013/TOCTA_EAP_web.pdf.Google Scholar
• Prasad A, Mahajan V (2003) How many pirates should a software firm tolerate? An analysis of piracy protection on the diffusion of software. Internat. J. Res. Marketing 20(4):337–353.Crossref, Google Scholar
• Qian Y (2014a) Brand management and strategies against counterfeits. J. Econom. Management Strategy 23(2):317–343.Crossref, Google Scholar
• Qian Y (2014b) Counterfeiters: Foes or friends? How counterfeits affect sales by product quality tier. Management Sci. 60(10):2381–2400.Link, Google Scholar
• Qian Y, Gong Q, Chen Y (2015) Untangling searchable and experiential quality responses to counterfeits. Marketing Sci. 34(4):522–538.Link, Google Scholar
• Rao RC, Syam N (2001) Equilibrium price communication and unadvertised specials by competing supermarkets. Marketing Sci. 20(1):61–81.Link, Google Scholar
• Ratchford BT (1982) Cost-benefit models for explaining consumer choice and information seeking behavior. Management Sci. 28(2):197–212.Link, Google Scholar
• Salop SC (1979) Monopolistic competition with outside goods. Bell J. Econom. 10(1):141–156.Crossref, Google Scholar
• Schendel S, MacClure R (2012) Drug companies fight take-back program for unused medicine. InvestigateWest (January 22). http://www.invw.org/article/drug-companies-fight-take-1243.Google Scholar
• Shy O, Thisse J-F (1999) A strategic approach to software protection. J. Econom. Management Strategy 8(2):163–190.Crossref, Google Scholar
• Sutton J (1991) Sunk Costs and Market Structure: Price Competition, Advertising, and the Evolution of Concentration (MIT Press, Cambridge, MA).Google Scholar
• Stone G (2005) Black market fertility drug trade grows, despite risks. ABC News (November 28). http://abcnews.go.com/WNT/Sex/story?id=1353245.Google Scholar
• Thomas K (2013) Facing black market, Pfizer is looking online to sell Viagra. New York Times (May 6). http://www.nytimes.com/2013/05/07/business/pfizer-begins-selling-viagra-online.html?_r=1&.Google Scholar
• Toscano P (2011) The dangerous world of counterfeit prescription drugs. CNBC.com (October 4). http://www.cnbc.com/id/44759526.Google Scholar
• U.S. Department of Justice (2012) The real cost of cheap online meds. Accessed April 8, 2016, http://www.justice.gov/opa/blog/real-cost-cheap-online-meds.Google Scholar
• Vernik DA, Purohit D, Desai PS (2011) Music downloads and the flip side of digital rights management. Marketing Sci. 30(6):1011–1027.Link, Google Scholar
• Visiongain (2012) Pharmaceutical anti-counterfeiting technologies: Market analysis 2012–2022. Accessed April 8, 2016, https://www.visiongain.com/Report/919/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2012-2022.Google Scholar
• Visiongain (2013) Pharmaceutical anti-counterfeiting technologies: Market analysis 2014–2024. Accessed April 8, 2016, https://www.visiongain.com/Report/1154/Pharmaceutical-Anti-counterfeiting-Technologies-Market-Analysis-2014-2024.Google Scholar
• Wilcox K, Sen S, Kim HM (2009) Why do consumers buy counterfeit luxury brands? J. Marketing Res. 46(2):247–259.Crossref, Google Scholar
• World Health Organization (2006a) Counterfeit medicines. AccessedApril 8, 2016, http://www.who.int/medicines/services/counterfeit/impact/TheNewEstimatesCounterfeit.pdf.Google Scholar
• World Health Organization (2006b) Counterfeit medicines: An update on estimates. Accessed April 8, 2016, http://www.who.int/medicines/services/counterfeit/impact/TheNewEstimatesCounterfeit.pdf.Google Scholar
• World Health Organization (2007) Anti-counterfeit technologies for the protection of medicines. Accessed April 8, 2016, http://www.who.int/impact/events/IMPACT-ACTechnologiesv3LIS.pdf.Google Scholar
• World Health Professions Alliance (2011) Background document on counterfeit medicines in Asia. Accessed April 8, 2016, http://www.whpa.org/background_document_counterfeit_medicines_in_asia.pdf.Google Scholar
• Xiao Y, Palekar U, Liu Y (2011) Shades of gray—The impact of gray markets on authorized distribution channels. Quant. Marketing Econom. 9(2):155–178.Crossref, Google Scholar
• Zhang J (2010) The sound of silence: Observational learning in the U.S. kidney market. Marketing Sci. 29(2):315–335.Link, Google Scholar
• Zhang J (2013) Policy and inference: The case of product labeling. Working paper, Massachusetts Institute of Technology, Cambridge.Google Scholar